Technology area: Biotechnology & Pharmaceuticals
20 pending office actions • 8 art units • 13 examiners • 0 of 20 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days
Natera Inc. has 18 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 13 examiners and 8 art units, showing meaningful distribution across its biotechnology prosecution work.
MUMMERT, STEPHANIE KANE is the busiest examiner, with 3 pending matters. The concentration is limited, so portfolio review should support consistent scientific and claim positions without assuming a single examiner-driven strategy.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (10%) |
| §103 only | 7 (35%) |
| §102 only | 1 (5%) |
| §112 only | 2 (10%) |
| Double-patenting only | 1 (5%) |
| Double-patenting + other | 5 (25%) |
| Multi-statute (no §101) | 2 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MUMMERT, STEPHANIE KANE | 5 | 61.4% | +21.2% |
| FLINDERS, JEREMY C | 2 | 63.5% | +17.0% |
| PRIEST, AARON A | 2 | 61.4% | +25.6% |
| GIAMMONA, FRANCESCA FILIPPA | 2 | 37.3% | +58.8% |
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.5% | +53.8% |
| GREENE, CAROLYN LEE | 1 | 65.7% | +46.1% |
| SITTON, JEHANNE SOUAYA | 1 | 53.2% | +47.5% |
| FONSECA LOPEZ, FRANCINI ALVARENGA | 1 | 28.6% | +30.0% |
| YU, TIAN NMN | 1 | 55.6% | +19.3% |
| YOUNG, BRIAN ELLIS | 1 | 65.0% | +28.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18220183 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | BERTAGNA, ANGELA MARIE | 22d overdue |
| 18294066 | METHODS FOR DETECTING NEOPLASM IN PREGNANT WOMEN | SITTON, JEHANNE SOUAYA | — |
| 18372565 | METHODS FOR ALLELE CALLING AND PLOIDY CALLING | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| 17842118 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | MUMMERT, STEPHANIE KANE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18227224 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | PRIEST, AARON A | 17d overdue |
| 18227219 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | PRIEST, AARON A | 15d overdue |
| 18111804 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | MUMMERT, STEPHANIE KANE | 54d |
| 19463001 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | FLINDERS, JEREMY C | — |
| 19463003 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | FLINDERS, JEREMY C | — |
| 19399491 | METHODS FOR TARGETED SEQUENCING OF CELL-FREE DNA | MUMMERT, STEPHANIE KANE | — |
| 18756518 | ASSESSING GRAFT SUITABILITY FOR TRANSPLANTATION | KAPUSHOC, STEPHEN THOMAS | — |
| 18751083 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | MUMMERT, STEPHANIE KANE | — |
| Art Unit | Apps |
|---|---|
| 1681 | 11 |
| 1684 | 2 |
| 1682 | 2 |
| 1683 | 1 |
| 1637 | 1 |
| 1685 | 1 |
| 1672 | 1 |
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19463001 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | FLINDERS, JEREMY C | 1684 | §102§103DP | Final Rejection | — | Pending | Jan 28, 2026 |
| 19463003 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | FLINDERS, JEREMY C | 1684 | §103§112DP | Final Rejection | — | Pending | Jan 28, 2026 |
| 19399491 | METHODS FOR TARGETED SEQUENCING OF CELL-FREE DNA | MUMMERT, STEPHANIE KANE | 1681 | §112Other | Non-Final OA | — | Pending | Nov 24, 2025 |
| 18756518 | ASSESSING GRAFT SUITABILITY FOR TRANSPLANTATION | KAPUSHOC, STEPHEN THOMAS | 1683 | §103DP | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18751083 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | MUMMERT, STEPHANIE KANE | 1681 | §103Other | Final Rejection | — | Pending | Jun 21, 2024 |
| 18680693 | METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA | GREENE, CAROLYN LEE | 1681 | §112DP | Non-Final OA | — | Pending | May 31, 2024 |
| 18632703 | SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER | MUMMERT, STEPHANIE KANE | 1637 | §103 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18294066 | METHODS FOR DETECTING NEOPLASM IN PREGNANT WOMEN | SITTON, JEHANNE SOUAYA | 1682 | §101§103 | Final Rejection | — | Pending | Jan 31, 2024 |
| 18372565 | METHODS FOR ALLELE CALLING AND PLOIDY CALLING | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§112DP | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18279006 | METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA IN TRANSPLANT RECIPIENTS OF MULTIPLE ORGANS | YU, TIAN NMN | 1681 | §103Other | Final Rejection | — | Pending | Aug 25, 2023 |
| 18227786 | METHODS FOR AMPLIFICATION OF CELL-FREE DNA USING LIGATED ADAPTORS AND UNIVERSAL AND INNER TARGET-SPECIFIC PRIMERS FOR MULTIPLEXED NESTED PCR | YOUNG, BRIAN ELLIS | 1672 | DP | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18227224 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | PRIEST, AARON A | 1681 | §102 | Final Rejection | 17d overdue | Pending | Jul 27, 2023 |
| 18227219 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | PRIEST, AARON A | 1681 | §102DP | Final Rejection | 15d overdue | Pending | Jul 27, 2023 |
| 18220183 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | BERTAGNA, ANGELA MARIE | 1681 | §103§112 | Final Rejection | 22d overdue | Pending | Jul 10, 2023 |
| 18111804 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | MUMMERT, STEPHANIE KANE | 1681 | §103Other | Final Rejection | 54d | Pending | Feb 20, 2023 |
| 17925693 | METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103 | Non-Final OA | — | Pending | Nov 16, 2022 |
| 17842118 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | MUMMERT, STEPHANIE KANE | 1681 | §102§103Other | Non-Final OA | — | Pending | Jun 16, 2022 |
| 17465424 | Systems and Methods for Detection of Aneuploidy | NEGIN, RUSSELL SCOTT | 1686 | §112 | Final Rejection | 13d | Pending | Sep 02, 2021 |
| 17413464 | METHODS FOR ANALYSIS OF CIRCULATING CELLS | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103 | Non-Final OA | — | Pending | Jun 11, 2021 |
| 16309271 | COMPOSITIONS AND METHODS FOR DETECTION OF NUCLEIC ACID MUTATIONS | SALMON, KATHERINE D | 1682 | §103 | Final Rejection | 1d overdue | Pending | Dec 12, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNatera Inc. has 20 pending office actions as of October 2026, spread across 8 art units and 13 examiners.
Stephanie Kane Mummert has the most, with 5 of Natera Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
